Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 7.345 0.335 (4.78%) Market Cap: 975.64 Mil Enterprise Value: 932.14 Mil PE Ratio: 0 PB Ratio: 2.37 GF Score: 82/100

Q2 2023 Maravai LifeSciences Holdings Inc Earnings Call Transcript

Aug 07, 2023 / 09:00PM GMT
Release Date Price: $11.02 (-4.17%)
Operator

Thank you for standing by. I would like to welcome everyone to the Quarter 2 2023 Maravai LifeSciences' Earnings Conference Call. (Operator Instructions)

I will now turn the conference over to Debra Hart. Deb, please go ahead.

Debra Hart
Maravai LifeSciences Holdings, Inc. - Senior Director of IR

Good afternoon, everyone. Thanks for joining us on our second quarter 2023 earnings call. Our press release and the slides that accompany today's call are posted on our website and are available at investors.maravai.com.

As you can see on our agenda on Slide 2, joining me today are Trey Martin, our new CEO; Kevin Herde, Chief Financial Officer; and Carl Hull, Executive Chairman of the Board. Drew Burch, Executive Vice President and General Manager of our Nucleic Acid Products; and Becky Buzzeo, our Chief Commercial Officer, will join the call for the question-and-answer session following the prepared remarks.

We remind you, management will make forward-looking statements and refer to GAAP and non-GAAP financial measures during today's call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot